One study, in which mass cytometry was used to evaluate the TME during early- and late-stage tumor development, showed that Flt3L injections vastly increases the numbers of CD103+ DCs in the TME (Salmon et al., 2016). This evidence concerns the gene ITGAE and neoplasm.